151 related articles for article (PubMed ID: 34310205)
1.
Shaheen SK; Juvvadi PR; Allen J; Shwab EK; Cole DC; Asfaw YG; Kapoor M; Shaw KJ; Steinbach WJ
Antimicrob Agents Chemother; 2021 Sep; 65(10):e0068221. PubMed ID: 34310205
[TBL] [Abstract][Full Text] [Related]
2. APX001 Is Effective in the Treatment of Murine Invasive Pulmonary Aspergillosis.
Gebremariam T; Alkhazraji S; Alqarihi A; Jeon HH; Gu Y; Kapoor M; Shaw KJ; Ibrahim AS
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455236
[TBL] [Abstract][Full Text] [Related]
3.
Pfaller MA; Huband MD; Flamm RK; Bien PA; Castanheira M
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182527
[TBL] [Abstract][Full Text] [Related]
4. Galactomannan Is a Biomarker of Fosmanogepix (APX001) Efficacy in Treating Experimental Invasive Pulmonary Aspergillosis.
Gebremariam T; Alkhazraji S; Gu Y; Singh S; Alqarihi A; Shaw KJ; Ibrahim AS
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31685475
[TBL] [Abstract][Full Text] [Related]
5. APX001 Pharmacokinetic/Pharmacodynamic Target Determination against
Zhao M; Lepak AJ; Marchillo K; Vanhecker J; Sanchez H; Ambrose PG; Andes DR
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670426
[TBL] [Abstract][Full Text] [Related]
6.
Shaw KJ; Schell WA; Covel J; Duboc G; Giamberardino C; Kapoor M; Moloney M; Soltow QA; Tenor JL; Toffaletti DL; Trzoss M; Webb P; Perfect JR
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891599
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of analogs of the Gwt1 inhibitor manogepix (APX001A) and in vitro evaluation against Cryptococcus spp.
Trzoss M; Covel JA; Kapoor M; Moloney MK; Soltow QA; Webb PJ; Shaw KJ
Bioorg Med Chem Lett; 2019 Dec; 29(23):126713. PubMed ID: 31668974
[TBL] [Abstract][Full Text] [Related]
8. Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis.
Alkhazraji S; Gebremariam T; Alqarihi A; Gu Y; Mamouei Z; Singh S; Wiederhold NP; Shaw KJ; Ibrahim AS
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818813
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Resistance Development to the Gwt1 Inhibitor Manogepix (APX001A) in
Kapoor M; Moloney M; Soltow QA; Pillar CM; Shaw KJ
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611349
[TBL] [Abstract][Full Text] [Related]
10. Fosmanogepix: A Review of the First-in-Class Broad Spectrum Agent for the Treatment of Invasive Fungal Infections.
Shaw KJ; Ibrahim AS
J Fungi (Basel); 2020 Oct; 6(4):. PubMed ID: 33105672
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Delayed Therapy with Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis.
Wiederhold NP; Najvar LK; Shaw KJ; Jaramillo R; Patterson H; Olivo M; Catano G; Patterson TF
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427304
[TBL] [Abstract][Full Text] [Related]
12. The Aspergillus fumigatus Mismatch Repair
Dos Reis TF; Silva LP; de Castro PA; do Carmo RA; Marini MM; da Silveira JF; Ferreira BH; Rodrigues F; Lind AL; Rokas A; Goldman GH
mSphere; 2019 Aug; 4(4):. PubMed ID: 31391280
[TBL] [Abstract][Full Text] [Related]
13. APX001 and Other Gwt1 Inhibitor Prodrugs Are Effective in Experimental
Viriyakosol S; Kapoor M; Okamoto S; Covel J; Soltow QA; Trzoss M; Shaw KJ; Fierer J
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455238
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics and dose-response relationships of liposomal amphotericin B against different azole-resistant Aspergillus fumigatus isolates in a murine model of disseminated aspergillosis.
Seyedmousavi S; Melchers WJ; Mouton JW; Verweij PE
Antimicrob Agents Chemother; 2013 Apr; 57(4):1866-71. PubMed ID: 23380732
[TBL] [Abstract][Full Text] [Related]
15. Fosmanogepix (APX001) Is Effective in the Treatment of Pulmonary Murine Mucormycosis Due to Rhizopus arrhizus.
Gebremariam T; Alkhazraji S; Alqarihi A; Wiederhold NP; Shaw KJ; Patterson TF; Filler SG; Ibrahim AS
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32205345
[TBL] [Abstract][Full Text] [Related]
16.
Hager CL; Larkin EL; Long L; Zohra Abidi F; Shaw KJ; Ghannoum MA
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311065
[No Abstract] [Full Text] [Related]
17. Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance programme (2018-2019).
Pfaller MA; Huband MD; Flamm RK; Bien PA; Castanheira M
J Glob Antimicrob Resist; 2021 Sep; 26():117-127. PubMed ID: 34051400
[TBL] [Abstract][Full Text] [Related]
18. Emergence of azole resistant-
Danion F; Duréault A; Gautier C; Senechal A; Persat F; Bougnoux ME; Givel C; Couderc LJ; Lortholary O; Garcia-Hermoso D; Lanternier F
J Med Microbiol; 2020 Jun; 69(6):844-849. PubMed ID: 32459615
[No Abstract] [Full Text] [Related]
19. Emerging aspergillosis by azole-resistant Aspergillus fumigatus at an intensive care unit in the Netherlands, 2010 to 2013.
van Paassen J; Russcher A; In 't Veld-van Wingerden AW; Verweij PE; Kuijper EJ
Euro Surveill; 2016 Jul; 21(30):. PubMed ID: 27541498
[TBL] [Abstract][Full Text] [Related]
20. Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?
Snelders E; Melchers WJ; Verweij PE
Future Microbiol; 2011 Mar; 6(3):335-47. PubMed ID: 21449843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
